147
http://www.DGS-PraxisLeitlinien.deNr.
Nachweis
293
Shaiova L, Mori M, Anderson K, Loewen G, Ghalie R, Homel P, Portenoy R. Administration
of morphine sulfate extended-release capsules via gastrostomy: dissolution study and
case reports. J Palliat Med 2007; 10(5): 1063-1067.
294
Sharma S, Rajagopal MR, Palat G, Singh C, Haji AG, Jain D. A phase II pilot study to
evaluate use of intravenous lidocaine for opioid-refractory pain in cancer patients. J Pain
Symptom Manage 2009; 37(1): 85-93.
295
Shin SW, Cho AR, Lee HJ, Kim HJ, Byeon GJ, Yoon JW, Kim KH, Kwon JY. Maintenance
anaesthetics during remifentanil-based anaesthesia might affect postoperative pain
control after breast cancer surgery. Br J Anaesth 2010; 105(5): 661-667.
296
Shirakami G, Teratani Y, Fukuda K. Nocturnal episodic hypoxemia after ambulatory breast
cancer surgery: comparison of sevoflurane and propofol-fentanyl anesthesia. J Anesth
2006; 20(2): 78-85.
297
Shirakami G, Teratani Y, Segawa H, Matsuura S, Shichino T, Fukuda K. Omission of fentanyl
during sevoflurane anesthesia decreases the incidences of postoperative nausea and vo-
miting and accelerates postanesthesia recovery in major breast cancer surgery. J Anesth
2006; 20(3): 188-195.
298
Sidiropoulou T, Buonomo O, Fabbi E, Silvi MB, Kostopanagiotou G, Sabato AF, Dauri M. A
prospective comparison of continuous wound infiltration with ropivacaine versus single-
injection paravertebral block after modified radical mastectomy. Anesth Analg 2008;
106(3): 997-1001.
299
Silvestri B, Bandieri E, Del Prete S, Ianniello GP, Micheletto G, Dambrosio M, Sabbatini G,
Endrizzi L, Marra A, Aitini E, Calorio A, Garetto F, Nastasi G, Piantedosi F, Sidoti V, Spanu P.
Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain
in Italian patients: results of an open-label, multicentre, observational study. Clin Drug
Investig 2008; 28(7): 399-407.
300
Singhal AK, Mishra S, Bhatnagar S, Singh R. Epidural morphine analgesia compared with
intravenous morphine for oral cancer surgery with pectoralis major myocutaneous flap
reconstruction. Acta Anaesthesiol Scand 2006; 50(2): 234-238.
301
SITTIG H.-B. Verbesserung der Lebensqualität in der Palliativtherapie durch Bisphospho-
nate bei Knochenmetastasen. Refresher Palliativmedizin. Stuttgart Thieme 2010; 1 (1):
R1 – R12.
302
Skiveren J, Haedersdal M, Philipsen PA, Wiegell SR, Wulf HC. Morphine gel 0.3% does not
relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo-
controlled study. Acta Derm Venereol 2006; 86(5): 409-411.
303
Slatkin NE, Rhiner MI, Gould EM, Ma T, Ahdieh H. Long-term tolerability and effectiveness
of oxymorphone extended release in patients with cancer. J Opioid Manag 2010; 6(3):
181-191.
304
Slatkin NE, Xie F, Messina J, Segal TJ. Fentanyl buccal tablet for relief of breakthrough pain
in opioid-tolerant patients with cancer-related chronic pain. J Support Oncol 2007; 5(7):
327-334.
Literaturverzeichnis